The global quinestrol market is expected to grow at a CAGR of 3.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing number of women in reproductive age group and rising awareness about contraception methods among women.
Levonorgestrel quinestrol tablets are expected to be the fastest-growing segment in the global quinestrol market during the forecast period, due to their high efficacy and low side effects as compared with other contraceptive pills. Norgestrel quinestrol tablets are also expected to grow at a significant rate due to their long-term effectiveness and low side effects as compared with other contraceptive pills.
Hospital pharmacies accounted for more than one-third share of total revenue generated from sales of contraceptives in 2017, owing to their higher demand for contraceptives among patients who need them for medical reasons such as birth control or treatment for menstrual disorders or endometriosis.
- Quinestrol is a synthetic form of estrogen that is used to treat breast cancer in postmenopausal women.
- Quinestrol is also used to treat prostate cancer, endometrial cancer, and uterine fibroids in postmenopausal women.
- The drug has been shown to be effective in the treatment of these cancers because it blocks the production of testosterone and estrogen by the ovaries and testes respectively, which are necessary for tumor growth.
- The drug can also be used as a contraceptive agent for men or women who have not had their uterus removed (hysterectomy).
- It can also be used as an emergency contraceptive if taken within 120 hours after unprotected sex or birth control failure (e.g., broken condom).
Industry Growth Insights published a new data on “Quinestrol (CAS 57-63-6) Market”. The research report is titled “Quinestrol (CAS 57-63-6) Market research by Types (Levonorgestrel Quinestrol Tablets, Norgestrel Quinestrol Tablets, Others), By Applications (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Players/Companies Zizhu Pharma, North China Pharma, Baijingyu Pharma, Advacare Pharma, AIS Hormones and Ancillaries”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Quinestrol (CAS 57-63-6) Market Research Report
By Type
Levonorgestrel Quinestrol Tablets, Norgestrel Quinestrol Tablets, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Zizhu Pharma, North China Pharma, Baijingyu Pharma, Advacare Pharma, AIS Hormones and Ancillaries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Quinestrol (CAS 57-63-6) Market Report Segments:
The global Quinestrol (CAS 57-63-6) market is segmented on the basis of:
Types
Levonorgestrel Quinestrol Tablets, Norgestrel Quinestrol Tablets, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zizhu Pharma
- North China Pharma
- Baijingyu Pharma
- Advacare Pharma
- AIS Hormones and Ancillaries
 Market Overview.svg)
Highlights of The Quinestrol (CAS 57-63-6) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Levonorgestrel Quinestrol Tablets
- Norgestrel Quinestrol Tablets
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Quinestrol (CAS 57-63-6) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Quinestrol is a synthetic estrogen and progestin. It is used to treat menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. Quinestrol may also be used to prevent heart disease in women who are at high risk for the condition.
Some of the key players operating in the quinestrol (cas 57-63-6) market are Zizhu Pharma, North China Pharma, Baijingyu Pharma, Advacare Pharma, AIS Hormones and Ancillaries.
The quinestrol (cas 57-63-6) market is expected to grow at a compound annual growth rate of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Quinestrol (CAS 57-63-6) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Quinestrol (CAS 57-63-6) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Quinestrol (CAS 57-63-6) Market - Supply Chain
4.5. Global Quinestrol (CAS 57-63-6) Market Forecast
4.5.1. Quinestrol (CAS 57-63-6) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Quinestrol (CAS 57-63-6) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Quinestrol (CAS 57-63-6) Market Absolute $ Opportunity
5. Global Quinestrol (CAS 57-63-6) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Type
5.3.1. Levonorgestrel Quinestrol Tablets
5.3.2. Norgestrel Quinestrol Tablets
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Quinestrol (CAS 57-63-6) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Quinestrol (CAS 57-63-6) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Quinestrol (CAS 57-63-6) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Quinestrol (CAS 57-63-6) Demand Share Forecast, 2019-2026
9. North America Quinestrol (CAS 57-63-6) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Type
9.7.1. Levonorgestrel Quinestrol Tablets
9.7.2. Norgestrel Quinestrol Tablets
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Quinestrol (CAS 57-63-6) Demand Share Forecast, 2019-2026
10. Latin America Quinestrol (CAS 57-63-6) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Type
10.7.1. Levonorgestrel Quinestrol Tablets
10.7.2. Norgestrel Quinestrol Tablets
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Quinestrol (CAS 57-63-6) Demand Share Forecast, 2019-2026
11. Europe Quinestrol (CAS 57-63-6) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Type
11.7.1. Levonorgestrel Quinestrol Tablets
11.7.2. Norgestrel Quinestrol Tablets
11.7.3. Others
1.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Quinestrol (CAS 57-63-6) Demand Share, 2019-2026
12. Asia Pacific Quinestrol (CAS 57-63-6) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Type
12.7.1. Levonorgestrel Quinestrol Tablets
12.7.2. Norgestrel Quinestrol Tablets
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Quinestrol (CAS 57-63-6) Demand Share, 2019-2026
13. Middle East & Africa Quinestrol (CAS 57-63-6) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Quinestrol (CAS 57-63-6) Market Size and Volume Forecast by Type
13.7.1. Levonorgestrel Quinestrol Tablets
13.7.2. Norgestrel Quinestrol Tablets
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Quinestrol (CAS 57-63-6) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Quinestrol (CAS 57-63-6) Market: Market Share Analysis
14.2. Quinestrol (CAS 57-63-6) Distributors and Customers
14.3. Quinestrol (CAS 57-63-6) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Zizhu Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. North China Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Baijingyu Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Advacare Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AIS Hormones and Ancillaries
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
